Novel drug combination unleashes apoptosis in AML

    loading  Checking for direct PDF access through Ovid

Abstract

The combination of p53 activation and Bcl-2 inhibition reciprocally overcomes apoptosis resistance and leads to synergistic efficacy in acute myeloid leukemia.

Related Topics

    loading  Loading Related Articles